| dc.creator | Geloneze B. | |
| dc.creator | Lamounier R.N. | |
| dc.creator | Coelho O.R. | |
| dc.date | 2006 | |
| dc.date | 2015-06-30T18:00:59Z | |
| dc.date | 2015-11-26T14:14:14Z | |
| dc.date | 2015-06-30T18:00:59Z | |
| dc.date | 2015-11-26T14:14:14Z | |
| dc.date.accessioned | 2018-03-28T21:15:05Z | |
| dc.date.available | 2018-03-28T21:15:05Z | |
| dc.identifier | | |
| dc.identifier | Arquivos Brasileiros De Cardiologia. , v. 87, n. 5, p. 604 - 613+660-670, 2006. | |
| dc.identifier | 0066782X | |
| dc.identifier | 10.1590/S0066-782X2006001800018 | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-33846369855&partnerID=40&md5=667cef32fc43507b36ab62a2fbe8650d | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/102682 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/102682 | |
| dc.identifier | 2-s2.0-33846369855 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1242482 | |
| dc.description | [No abstract available] | |
| dc.description | 87 | |
| dc.description | 5 | |
| dc.description | 604 | |
| dc.description | 613+660-670 | |
| dc.description | De Fronzo, R.A., Lilly lecture 1987. The triumvirate: Beta cell, muscle, liver. A collusion responsible for IDDM (1988) Diabetes, 37, pp. 667-687 | |
| dc.description | Stratton, I.M., Adler, A.I., Neil, H.A., Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study (2000) BMJ, 321, pp. 405-412 | |
| dc.description | Standards of care for patients with diabetes mellitus (Position Statement) (2004) Diabetes Care, (SUPPL. 1), pp. S15-S35. , American Diabetes Association | |
| dc.description | Glucose tolerance and cardiovascular mortality (2001) Arch Intern Med, 161, pp. 397-405. , DECODE Study Group | |
| dc.description | Dinneen, S., Gerich, J., Rizza, R., Carbohydrate metabolism in non-insulin dependent diabetes mellitus (1992) N Engl J Med, 327, pp. 707-713 | |
| dc.description | Gavin III, J.R., Pathophysiologic mechanisms of postprandial hyperglycemia (2001) Am J Cardiol, 88 (SUPPL. 1), pp. 4H-8H | |
| dc.description | Lebovitz HE. A Symposium: Managing the atherogenic potential of the postprandial state. Am J Cardiol 2001 | |
| dc.description | 88(Suppl 1): 1H-3HMeyer, U., Gressner, A.M., Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin (2004) Clinical Chemistry, 50 (9), pp. 1511-1525 | |
| dc.description | Polonsky, K.S., Given, B.D., Hirsch, L.J., Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1988) N Engl J Med, 318, pp. 1231-1239 | |
| dc.description | Hall, L.D., Westland, R.E., Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects (1983) Diabetologia, 25, pp. 316-321. , Service FJ | |
| dc.description | Yaney, G.C., Corkey, B.E., Fatty acid metabolism and insulin secretion in pancreatic beta cells (2003) Diabetologia, 46 (10), pp. 1297-1212 | |
| dc.description | Kahn, S.E., The importance of beta-cell in the pathogenesis of type 2 diabetes melitus (2000) Am J Med, 108, pp. 2S-8S | |
| dc.description | Poitout, V., Robertson, R.P., Minireview: Secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity (2002) Endocrinology, 143, pp. 339-342 | |
| dc.description | McKillop AM, Abdel-Wahab YH, Mooney MH, et al. Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity. Diabetes Metab 2002 | |
| dc.description | 28: 3S61-69Visboll, T., Holst, J.J., Incretins, insulin secretion and Type 2 diabetes mellitus (2004) Diabetologia, 47 (3), pp. 357-366 | |
| dc.description | Bruce, D.G., Storlien, L.H., Furler, S.M., Chisholm, D.J., Cephalic phase metabolic responses in normal weight adults (1987) Metabolism, 36, pp. 721-725 | |
| dc.description | Mitrakou, A., Kelley, D., Mokan, M., Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance (1992) N Engl J Med, 326, pp. 22-29 | |
| dc.description | Luzi, L., De Fronzo, R.A., Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans (1989) Am J Physiol, 257, pp. E241-E246 | |
| dc.description | Consoli, A., Nurjhan, N., Capani, F., Gerich, J., Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM (1989) Diabetes, 38, pp. 550-557 | |
| dc.description | Del Prato, S., Marchetti, P., Bonadonna, R.C., Phasic insulin release and metabolic regulation in type 2 diabetes (2002) Diabetes, 51 (SUPPL. 1), pp. S109-S116 | |
| dc.description | Weyer, C., Borgadus, C., Mott, D.M., Pratley, R.E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus (1999) J Clin Invest, 104, pp. 787-794 | |
| dc.description | Freskens, E.J., Kromhout, D., Glucose tolerance and the risk of cardiovascular disease: The Zutphen Study (2001) J Clin Epidemiol, 54, pp. 869-876 | |
| dc.description | Haffner, S.M., Lehto, S., Ronnemma, T., Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction (1998) N Engl J Med, 339, pp. 229-234 | |
| dc.description | Avezum, A., Piegas, L.S., Pereira, J.C.R., Risk factors associated with acute miocardial infarction in the São Paulo metropolitan region. A developed region in a developing country (2005) Arq Bras Cardiol, 84 (3), pp. 206-213 | |
| dc.description | Moraes, S.A., de Souza, J.M., Diabetes Mellitus and ischemic heart disease. Comparison by gender (1996) Arq Bras Cardiol, 66 (2), pp. 59-63 | |
| dc.description | Matsubara, B.B., Okoshi, K., Okoshi, M.P., Arterial dysfunction as a possible mechanism of cardiac injury in type. A Doppler-echocardiographic study (1997) Arq Bras Cardiol, 69 (3), pp. 155-159 | |
| dc.description | Kannel, W.B., McGee, D.L., Diabetes and cardivascular disease. The Framingham study (1979) JAMA, 241, pp. 2035-2038 | |
| dc.description | Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D., Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Interventional Trial (1993) Diabetes Care, 16, pp. 434-444 | |
| dc.description | Lee, W.L., Cheung, A.M., Cape, D., Zinman, B., Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies (2000) Diabetes Care, 23, pp. 962-968 | |
| dc.description | Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) Lancet, 352, pp. 837-853. , UK Prospective Diabetes Study Group | |
| dc.description | Laakso, M., Hyperglycemia and cardiovascular disease in type 2 diabetes (1999) Diabetes, 48, pp. 937-942 | |
| dc.description | De Vegt, F., Dekker, J.M., Ruhè, H.G., Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study (1999) Diabetologia, 42, pp. 926-931 | |
| dc.description | Donahue, R.P., Abbott, R.D., Reed, D.M., Yano, K., Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program (1987) Diabetes, 36, pp. 689-692 | |
| dc.description | Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria (1999) Lancet, 354, pp. 617-621. , The DECODE Study Group, the European Diabetes Epidemiology Group | |
| dc.description | Coutinho, M., Gerstein, H.C., Wang, Y., Yusuf, S., The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years (1999) Diabetes Care, 22, pp. 233-240 | |
| dc.description | Fuller, J.H., Shipley, M.J., Rose, G., Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study (1980) Lancet, 8183, pp. 1373-1376 | |
| dc.description | Fontbonne, A., Eschwege, E., Cambien, F., Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study (1989) Diabetologia, 32 (5), pp. 300-304 | |
| dc.description | Pyorala, K., Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland (1979) Diabetes Care, 2 (2), pp. 131-141 | |
| dc.description | Bahia, L., Gomes, M.B., da Cruz, P.D.M., Gonçalves, M.D.F., Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus (1999) Arq Bras Cardiol, 73 (1), pp. 11-22 | |
| dc.description | Zilversmidt, D.B., Atherogenesis: A postprandial phenomenon (1979) Circulation, 60, pp. 473-485 | |
| dc.description | Groot, P.H.E., Van Stiphout, W.A.H.J., Krauss, X.H., Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease (1991) Arterioscler Thromb, 11, pp. 653-662 | |
| dc.description | Patsch, J.R., Miesenböck, G., Hopferwieser, T., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state (1992) Arterioscler Thromb, 12, pp. 1336-1345 | |
| dc.description | Mamo, J.C.L., Proctor, S.D., Smith, D., Retention of chylomicron remnants by arterial tissue | |
| dc.description | importance of an efficient clearance mechanism from plasma (1998) Atherosclerosis, 141 (SUPPL.), pp. S63-S69 | |
| dc.description | Miesenböck, G., Patsch, J.R., Postprandial hyperlipidemia: The search for the atherogenic lipoprotein (1992) Curr Opin Lipidol, 3, pp. 196-201 | |
| dc.description | Ginsberg, H.N., Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogenesis (1991) Diabetes Care, 14, pp. 839-855 | |
| dc.description | Ginsberg, H.N., Lipoprotein physiology (1998) Endocrinol Metabol Clin North Am, 27, pp. 503-519 | |
| dc.description | Pastch, J., Influence of lipolysis on chylomicron clearance and HDL cholesterol levels (1998) Eur Heart J, 19 (SUPPL. H), pp. H2-H6 | |
| dc.description | Ginsberg, H.N., Illingworth, D.R., Postprandial dyslipidemia: An atherogenic disorder common on patients with diabetes mellitus.Am (2001) J Cardiol, 11 (SUPPL.), pp. 4H-8H | |
| dc.description | Daughert, Y.A., Lange, L.G., Sobel, B.E., Schonfeld, G., Aortic accumulation and plasma clearance of beta-VLDL and HDL: Effects of diet-induced hypercholesterolemia in rabbits (1985) J lipid Res, 16, pp. 955-963 | |
| dc.description | Rapp, J.H., Lespine, A., Hamilton, R.L., Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosortion from human atherosclerotic plaque (1994) Artherioscler Thromb, 14, pp. 1767-1774 | |
| dc.description | Cohn, J.S., Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease (2002) Current Opinion in Lipidology, 13 (1), pp. 19-24 | |
| dc.description | Frayn, K.N., Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad (2002) Med Princ Pract, 11 (SUPPL. 2), pp. 31-40 | |
| dc.description | Lebovitz, H.E., Effect of the postprandial state on nontraditional risk factors.Am (2001) J Cardiol, 88 (SUPPL.), pp. 20H-25H | |
| dc.description | Haller, H., Postprandial glucose and vascular disease (1997) Diabetic Medicine, 14, pp. S50-S56 | |
| dc.description | Giuliano, D., Marfella, R., Coppola, L., Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia (1997) Circulation, 95, pp. 1783-1790 | |
| dc.description | Heine, R.J., Dekker, J.M., Beyond postprandial hyperglycaemia: Metabolic factors associated with cardiovascular disease (2002) Diabetologia, 45, pp. 461-475 | |
| dc.description | Lee, I.K., Kim, H.S., Bae, J.H., Endothelial dysfunction: Its relantionship with acute hyperglycemia and hyperlipidemia (2002) Int J Clin Pract, 129 (SUPPL.), pp. 59-64 | |
| dc.description | Marfella, R., Verrazzo, G., Acampora, R., Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects (1995) Am J Physiol, 268, pp. E1167-E1173 | |
| dc.description | Beckman, J.A., Goldfine, A.B., Gordon, M.B., Creager, M.A., Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans (2001) Circulation, 103, pp. 1618-1623 | |
| dc.description | Ceriello, A., Quagliaro, L., Piconi, L., Effect of postprandial hypertrigliceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment (2004) Diabetes, 53, pp. 701-710 | |
| dc.description | Ceriello, A., Giugliano, D., Quatraro, A., Blood glucose may condition factor VII levels in diabetic and normal subjects (1988) Diabetologia, 31, pp. 889-891 | |
| dc.description | Ceriello, A., Giacomello, R., Stel, G., Hyperglycemia-induced thrombin formation in diabetes: The possible role of the oxidative stress (1995) Diabetes, 44, pp. 924-928 | |
| dc.description | Sakamoto, T., Ogawa, H., Kawano, H., Rapid change of platelet aggregability in acute hyperglycemia: Detection by a novel laser-light scattering method (2000) Thromb Haemost, 83, pp. 475-479 | |
| dc.description | Jones, R.L., Peterson, C.M., Reduced fibrinogen survival in diabetes mellitus a reversible phenomenon (1979) J Clin Invest, 63, pp. 485-493 | |
| dc.description | Ceriello, A., Falleti, E., Motz, E., Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: The possible role of oxidative stress (1998) Horm Metab Res, 30, pp. 146-149 | |
| dc.description | Marfella, R., Esposito, K., Giunta, R., Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia (2000) Circulation, 101, pp. 2247-2251 | |
| dc.description | Van Osostrom, A.J.H.H.M., Sijmonsma, T.P., Verseyden, C., Postprandial recruitment of neutrophils may contribuye to endotelial dysfunction (2003) J Lipid Res, 44, pp. 576-583 | |
| dc.description | Woerle, H.J., Pimenta, W.P., Meyer, C., Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values (2004) Arch Intern Med, 164, pp. 1627-1632 | |
| dc.description | The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management. Endocr Pract 2002 | |
| dc.description | 8 Suppl 1, 40-82Consenso Brasileiro sobre Diabetes 2002. Diagnóstico e classificação do diabetes melito e tratamento do diabetes melito do tipo 2. Rio de Janeiro: Diagraphic Editora | |
| dc.description | 2003De Venciana Major, C.A., Morgan, M.A., Tamerou, A., Toohey, J.S., Lien, J.M., EVANS, A.T., Postprandial versus preprandial blood glucose monitoring in women with gestacional diabetes mellitus requiring insulin therapy (1995) N Engl J Med, 333, pp. 1237-1241 | |
| dc.description | Bastyr, E.J., Stuart, C.A., Brodows, R.G., Therapy Focused on Lowering Postprandial Glucose, Not Fasting Glucose, May be Superior for Lowering HbA1c (2000) Diabetes Care, 23, pp. 1236-1241 | |
| dc.description | Monnier, L., Lapinski, H., Colette, C., Contributions of fasting and postprandial plasma glucose increments to overall diurnal hyperglycemia of type 2 diabetic patients (2003) Diabetes Care, 26, pp. 881-885 | |
| dc.description | Larsen, J.J., Dela, F., Kjaer, M., Galvo, H., The effect of intense exercise on postprandial glucose homeostasis in type 2 diabetic patients (1999) Diabetologia, 42, pp. 1282-1292 | |
| dc.description | Poirier, P., Mawhinney, S., Grondin, L., Prior meals enhances the plasma glucose lowering effect exercise in type 2 diabetes (2001) Med Sci Sports Exerc, 33, pp. 1259-1264 | |
| dc.description | Gill, J.M.R., Hardman, A.E., Postprandial lipemia: Effects of exercise and restriction of energy intake compared (2000) Am J Clin Nutr, 71, pp. 465-471 | |
| dc.description | Wolever, T.M., Bolgnesi, C., Source and amount of carbohydrate affect postprandial glucose and insulin in normal subjects (1996) J Nutr, 126, pp. 2798-2806 | |
| dc.description | Brenelli, S.L., Campos, S.D.S., Saad, M.J.A., Viscosity of gums in vitro and their ability to reduce postprandial hyperglycemia in normal subjects (1997) Brazilian J Med and Biol Res, 30, pp. 1437-1440 | |
| dc.description | Sheard, N.F., Clark, N.G., Brand-Miller, J.C., Dietary carbohydrate (amount and type) in the prevention and management of diabetes. A Statement by the American Diabetes Association (2004) Diabetes Care, 27 (9), pp. 2266-2271 | |
| dc.description | Hu, F.B., Willet, W.C., Optimal diets for prevention of coronary heart disease (2002) JAMA, 288, pp. 2569-2578 | |
| dc.description | Freiberg, M.S., Cabral, H.J., Heeren, T.C., Alcohol Consumption and the prevalence of the Metabolic Syndrome in the U.S (2004) Diabetes Care, 27, pp. 2954-2959 | |
| dc.description | Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002) N Engl J Med, 346, pp. 393-403. , Diabetes Prevention Program Research Group | |
| dc.description | Clark, H.E., Mattews, D.R., The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus (1996) Horm Metab Res, 28, pp. 445-450 | |
| dc.description | Ashcroft, F.M., Mechanisms of the glycaemic effercts of sulfonylureas (1996) Horm Metab Res, 28, pp. 456-463 | |
| dc.description | Shapiro, E.T., Van Cauter, E., Tillil, H., Glyburide enhances the responsiveness of the beta cell to glucose but does not correct the abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus (1989) J Clin Endocrinol Metab, 69, pp. 571-576 | |
| dc.description | Dabrowski, M., Wahl, P., Holmes, W.E., Ashcroft, F.M., Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels (2001) Diabetologia, 44, pp. 747-756 | |
| dc.description | Dornhorst, A., Insulinotropic meglitinide analogues (2001) Lancet, 358, pp. 1709-1716 | |
| dc.description | Nattrass, M., Lauritzen, T., Review of prandial glucose regulation with repaglinide: A solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes? (2000) International Journal of Obesity, 24 (SUPPL. 3), pp. S21-S31 | |
| dc.description | Tankova, T., Dragomir, K., Dakovska, L., KiriloVG, The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients (2003) Diab Res Clin Pract, 59, pp. 43-49 | |
| dc.description | Hanefeld, M., Bouter, K.P., Dickinson, S., Guitard, C., Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia (2000) Diabetes Care, 23, pp. 202-207 | |
| dc.description | Inzucchi, S.E., Oral Antihyperglycemic Therapy for Type 2 Diabetes. Scientific Review (2002) JAMA, 287, pp. 360-372 | |
| dc.description | Bailey, C., Biguanides and NIDD (1992) Diabetes Care, 15 (2), pp. 755-772 | |
| dc.description | Bailey, C.J., Turner, R.C., Metformin (1996) N Engl J Med, 334, pp. 574-579 | |
| dc.description | Fery, F., Plat, L., Balasse, E.O., Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients (1997) Metabolism, 46 (2), pp. 227-233 | |
| dc.description | Effect of intensive glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (1998) Lancet, 352, pp. 854-865. , UK Prospective Diabetes Study Group | |
| dc.description | Day, C., Thiazolidinediones: A new class of antidiabetic drugs (1999) Diabetic Med, 16, pp. 1-14 | |
| dc.description | Rosen, E.D., Spiegelman, B.M., PPAR-γ: A nuclear regulator of metabolism, differentiation, and cell growth (2001) J Biol Chem, 276, pp. 37731-37734 | |
| dc.description | Raskin, P., Rappaport, E.B., Cole, S.T., Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes (2000) Diabetologia, 43, pp. 278-284 | |
| dc.description | Fonseca, V., Grunberger, G., Gupta, S., Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control (2003) Diabetes Care, 26 (6), pp. 1685-1690 | |
| dc.description | Lebovitz, H.E., Alfa-Glucosidase inhibitors as agents in the treatment of diabetes (1998) Diabetes Revs, 6, pp. 132-145 | |
| dc.description | Holman RR, Cull CA, Turner RC on Behalf of The UKPDS Study GROUP. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999 | |
| dc.description | 22(6): 960-4Hirsh, I.B., Insulin Analogues (2005) N Engl J Med, 352, pp. 174-183 | |
| dc.description | Evans, M., Anderson, R.A., Smith, J.C., Khan, N., Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus (2003) Europ J Clin Invest, 33, pp. 231-238 | |
| dc.description | Ceriello, A., Cavarape, A., Martinelli, L., The post-prandial state in Type 2 diabetes and endothelial dysfunction: Effects of insulin aspart (2004) Diabet Med, 21, pp. 171-175 | |
| dc.description | Hermansen, K., Colombo, M., Storgaard, H., Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic human insulin in patients with type 2 diabetes (2002) Diabetes Care, 25 (5), pp. 883-888 | |
| dc.description | Raskin, P., Allen, E., Hollander, P., Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs (2005) Diabetes Care, 28 (2), pp. 260-265 | |
| dc.description | Odegard, P.S., Capoccia, K.L., Inhaled Insulin: Exubera (2005) Ann Pharmacother, 39, pp. 843-853 | |
| dc.description | Turner, R.C., Cull, C.A., Frighi, V., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirements for multiple therapies (1999) JAMA, 281, pp. 2005-2012 | |
| dc.description | Vuskan, V., Sievenpiper, J.L., Koo, V.Y.Y., American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus (2000) Arch Intern Med, 160, pp. 1009-1013 | |
| dc.description | Levetan, C., Want, L.L., Weyer, C., Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagons, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps (2003) Diabetes Care, 26, pp. 1-8 | |
| dc.description | Weyer, C., Gottleb, A., Kim, D.D., Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes (2003) Diabetes Care, 26, pp. 3074-3079 | |
| dc.description | Edwards, C.M., Stanley, S.A., DaVis, R., Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers (2001) Am J Physiol Endocrinol Metab, 281, pp. E155-E161 | |
| dc.description | Juhl, C.B., Hollingdal, M., Sturis, J., Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes (2002) Diabetes, 51, pp. 424-429 | |
| dc.description | Kolterman, O.G., Buse, J.B., Fineman, M.S., Synthetic Exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes (2003) J Clin Endocrinol Metab, 88, pp. 3082-3089 | |
| dc.description | Ahrén, B.O., Simonsson, E., Larsson, H., Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes (2002) Diabetes Care, 25, pp. 869-875 | |
| dc.language | pt | |
| dc.language | en | |
| dc.publisher | | |
| dc.relation | Arquivos Brasileiros de Cardiologia | |
| dc.rights | aberto | |
| dc.source | Scopus | |
| dc.title | Postprandial Hyperglycemia: Treating Its Atherogenic Potential [hiperglicemia Pós-prandial: Tratamento Do Seu Potencial Aterogênico] | |
| dc.type | Artículos de revistas | |
